Clinical trial
Evaluate the Safety and Efficacy of Repetitive, Transorbital Alternating Current Stimulation (rtACS) for the Treatment of Glaucoma
NCT05626491 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluate the Safety and Efficacy of Repetitive, Transorbital Alternating Current Stimulation (rtACS) for the Treatment of Glaucoma
- Lead sponsor
- Stanford University
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 28, 2023
- Completion date
- June 30, 2027
- Enrollment
- 45 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.